Arkolith/Insider Trading/NBY/Form 4

Hall Justin

CEO, GC and Director, DirectorNovaBay Pharmaceuticals, Inc. (NBY) · full profile →Form 4 · filed Dec 6, 2021
Net Buying
Open-Market Buys
$30K
Open-Market Sells
$0
Net Open-Market Flow
$30K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 6, 2021Buy(P)70K$0.43$30K73K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-21-027958) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML